Ladenburg Thalmann Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $336

Benzinga · 1d ago
Ladenburg Thalmann analyst Jeffrey Cohen initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $336.